RE:RE:RE:RE:RE:RE:RE:RE:Moving at pace No evidence and I am new to how fully consolidated acquisitions work. That comment was based on the fact we seem to be paying very different prices for different amounts of earnings. --- RXI was purchased for 9 million total payout contributing 16.6 million in revenue but with poor EBITDA
- VisionPros for 100 million total payout for 22 million revenue with EBITDA of 10%
- Oncidiumand for 100 million payout for 40 million revenue and 14% EBITDA.
My assumption was that the hugely different prices would reflect either a difference in assets or liabilities in the acquired company but they are all private so I have no information to base this off of. If there is another explanation I would love to have that clarified.
Tuatara wrote: Q3 report, they had $1.83MM of Debt against $55MM in Assets.
I havent read anything in any of the terms sheets that reports debt-carry with any of the acquisitions. Bankers etc are all paid in shares so any costs should be limited to legal and consultancy fees imho.
Have you seen any debt highlihghted within any of the recent term sheets that I may have missed?